|
Name |
(E,Z)-2,4-Decadienal
|
Molecular Formula | C10H16O | |
IUPAC Name* |
(2E,4Z)-deca-2,4-dienal
|
|
SMILES |
CCCCC/C=C\C=C\C=O
|
|
InChI |
InChI=1S/C10H16O/c1-2-3-4-5-6-7-8-9-10-11/h6-10H,2-5H2,1H3/b7-6-,9-8+
|
|
InChIKey |
JZQKTMZYLHNFPL-NMMTYZSQSA-N
|
|
Synonyms |
(E,Z)-2,4-Decadienal; (2E,4Z)-deca-2,4-dienal; 25152-83-4; 2E,4Z-Decadienal; 2e,4e-decadienal; 2-trans,4-trans-decadienal; (E,E)-2,4-Decanedienal; (E,E)-deca-2,4-dienal; Deca-2(E),4(E)-dienal; (E)-2,(E)-4-decadienal; trans-2,cis-4-Decadienal; 2,4-Decadienal, (E,Z)-; 2,4-Decadienal, (2E,4Z)-; (2E,4Z)-Decadienal; (E,E)-2,4-Decadecenal; Deca-2(E),4(Z)-dienal; SCHEMBL1301734; DTXSID9058739; FEMA 3135; LMFA06000146; ZINC13433325
|
|
CAS | 25152-83-4 | |
PubChem CID | 6427087 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 152.23 | ALogp: | 3.2 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.245 |
Caco-2 Permeability: | -4.562 | MDCK Permeability: | 0.00002610 |
Pgp-inhibitor: | 0.007 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.019 |
Blood-Brain-Barrier Penetration (BBB): | 0.992 | Plasma Protein Binding (PPB): | 47.64% |
Volume Distribution (VD): | 1.185 | Fu: | 31.65% |
CYP1A2-inhibitor: | 0.457 | CYP1A2-substrate: | 0.679 |
CYP2C19-inhibitor: | 0.095 | CYP2C19-substrate: | 0.769 |
CYP2C9-inhibitor: | 0.031 | CYP2C9-substrate: | 0.763 |
CYP2D6-inhibitor: | 0.028 | CYP2D6-substrate: | 0.832 |
CYP3A4-inhibitor: | 0.05 | CYP3A4-substrate: | 0.212 |
Clearance (CL): | 5.601 | Half-life (T1/2): | 0.687 |
hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.414 |
Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.884 |
Rat Oral Acute Toxicity: | 0.891 | Maximum Recommended Daily Dose: | 0.81 |
Skin Sensitization: | 0.984 | Carcinogencity: | 0.648 |
Eye Corrosion: | 0.984 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.961 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001600 | 1.000 | D0UE9X | 0.313 | ||||
ENC001724 | 0.838 | D01QLH | 0.293 | ||||
ENC001597 | 0.750 | D0O1TC | 0.288 | ||||
ENC001598 | 0.686 | D06FEA | 0.235 | ||||
ENC001599 | 0.632 | D0O1PH | 0.228 | ||||
ENC001654 | 0.606 | D0N3NO | 0.221 | ||||
ENC001601 | 0.585 | D0OR6A | 0.217 | ||||
ENC001683 | 0.472 | D0AY9Q | 0.197 | ||||
ENC005508 | 0.464 | D09SRR | 0.191 | ||||
ENC005507 | 0.448 | D0G2MW | 0.190 |